Literature DB >> 18547117

Anti-HIV-1 protease activity of lanostane triterpenes from the vietnamese mushroom Ganoderma colossum.

Riham Salah El Dine1, Ali M El Halawany, Chao-Mei Ma, Masao Hattori.   

Abstract

Four new lanostane triterpenes, colossolactone V (1), colossolactone VI (2), colossolactone VII (3), and colossolactone VIII (4), were isolated from the fruiting bodies of the Vietnamese mushroom Ganoderma colossum, together with the known compound colossolactone E (5). The structures of 1- 4 were assigned on the basis of spectroscopic evidence, and their absolute configurations were determined by CD spectroscopy and the Mosher ester method. Compounds 1- 5, as well as two previously isolated compounds [schisanlactone A (6) and colossolactone G (7)] from the same mushroom, were evaluated for inhibition of HIV-1 protease, with IC 50 values for the most potent compounds ranging from 5 to 13 microg/mL.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18547117     DOI: 10.1021/np8001139

Source DB:  PubMed          Journal:  J Nat Prod        ISSN: 0163-3864            Impact factor:   4.050


  18 in total

Review 1.  Recent Progress in the Development of HIV-1 Protease Inhibitors for the Treatment of HIV/AIDS.

Authors:  Arun K Ghosh; Heather L Osswald; Gary Prato
Journal:  J Med Chem       Date:  2016-01-22       Impact factor: 7.446

Review 2.  Medicinal mushroom: boon for therapeutic applications.

Authors:  Vivek Kumar Chaturvedi; Sonam Agarwal; Krishna Kumar Gupta; Pramod W Ramteke; M P Singh
Journal:  3 Biotech       Date:  2018-07-23       Impact factor: 2.406

Review 3.  Plant-derived triterpenoids and analogues as antitumor and anti-HIV agents.

Authors:  Reen-Yen Kuo; Keduo Qian; Susan L Morris-Natschke; Kuo-Hsiung Lee
Journal:  Nat Prod Rep       Date:  2009-08-13       Impact factor: 13.423

Review 4.  Mushrooms: an emerging resource for therapeutic terpenoids.

Authors:  Adhiraj Dasgupta; Krishnendu Acharya
Journal:  3 Biotech       Date:  2019-09-24       Impact factor: 2.406

Review 5.  Accessing biological actions of Ganoderma secondary metabolites by in silico profiling.

Authors:  Ulrike Grienke; Teresa Kaserer; Florian Pfluger; Christina E Mair; Thierry Langer; Daniela Schuster; Judith M Rollinger
Journal:  Phytochemistry       Date:  2014-11-06       Impact factor: 4.072

Review 6.  Traditional uses, chemical components and pharmacological activities of the genus Ganoderma P. Karst.: a review.

Authors:  Li Wang; Jie-Qing Li; Ji Zhang; Zhi-Min Li; Hong-Gao Liu; Yuan-Zhong Wang
Journal:  RSC Adv       Date:  2020-11-18       Impact factor: 4.036

Review 7.  Potential of small-molecule fungal metabolites in antiviral chemotherapy.

Authors:  Biswajit G Roy
Journal:  Antivir Chem Chemother       Date:  2017-07-23

Review 8.  Current and future perspective on antimicrobial and anti-parasitic activities of Ganoderma sp.: an update.

Authors:  Buddha Bahadur Basnet; Li Liu; Li Bao; Hongwei Liu
Journal:  Mycology       Date:  2017-05-24

Review 9.  A bioactivity versus ethnobotanical survey of medicinal plants from Nigeria, west Africa.

Authors:  Lydia L Lifongo; Conrad V Simoben; Fidele Ntie-Kang; Smith B Babiaka; Philip N Judson
Journal:  Nat Prod Bioprospect       Date:  2014-03-02

10.  Anticancer effect of triterpenes from Ganoderma lucidum in human prostate cancer cells.

Authors:  Lijun Qu; Sumei Li; Yumin Zhuo; Jianfan Chen; Xiaoping Qin; Guoqing Guo
Journal:  Oncol Lett       Date:  2017-10-09       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.